|
|
Article: NeoPharm Announces Cintredekin Besudotox Poster Presentation at 55th Annual Meeting of the Congress of Neurological Surgeons (CNS).
- Article from:
- Business Wire
- Article date:
- October 4, 2005
CopyrightCOPYRIGHT 2005 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
NeoPharm, Inc. (Nasdaq/NM:NEOL):
Who/What: NeoPharm, Inc. (Nasdaq/NM:NEOL) cintredekin besudotox
(IL13-PE38QQR) poster presentation
Why: Preliminary safety and tolerability data for cintredekin
besudotox in the treatment of newly-diagnosed malignant
glioma
Where:Hynes Convention Center
Digital Poster Center, Exhibit Hall D, 2nd Floor
Boston, MA
When: Monday, October 109:00 a.m. - 4:30 p.m.
Tuesday, October 11 9:00 a.m. - 4:30 p.m.
Wednesday, October 12 9:00 a.m. - 4:00 p.m.
Electronic Poster Format
Posters can be searched ...